Dicot Pharma Releases Q3 2026 Interim Report
Dicot Pharma published its Q3 2026 interim report and is scheduled to present it in a webcast today at 1:00 p.m. CEST.
Related stories
Woodside Signs 20-Year LNG Offtake Agreement With QatarEnergy
Woodside Energy signed a 20-year LNG sale and purchase agreement with QatarEnergy.
M impact | EQUITY | Oct 29, 2026, 09:46 AM UTC
Southside Bancshares Reports Third-Quarter 2026 Financial Results
Southside Bancshares reported results for the quarter ended September 30, 2026, including earnings per diluted common share of $0.93.
M impact | EQUITY | Oct 29, 2026, 09:46 AM UTC
STMicro lifts data centre revenue forecast after Q3 profit beat
STMicro raised its data centre revenue forecast after reporting a third-quarter profit beat.
M impact | EQUITY | Oct 29, 2026, 09:46 AM UTC
Eldorado Gold Q3 Adjusted Net Earnings Rise, 2026 Production Guidance Cut
Eldorado Gold reported higher Q3 adjusted net earnings year over year and cut its 2026 production guidance.
M impact | EQUITY | Oct 29, 2026, 09:46 AM UTC
Sheng Siong Q3 revenue rises 6.2% on store expansion
Singapore supermarket operator Sheng Siong reported a 6.2% rise in Q3 revenue, citing store expansion.
M impact | EQUITY | Oct 29, 2026, 09:45 AM UTC
Southside Bancshares Reports Q3 Pretax Profit of $34.26 Million
M impact | EQUITY | Oct 29, 2026, 09:45 AM UTC